Literature DB >> 20679538

Non-small cell lung cancer.

David S Ettinger1, Wallace Akerley, Gerold Bepler, Matthew G Blum, Andrew Chang, Richard T Cheney, Lucian R Chirieac, Thomas A D'Amico, Todd L Demmy, Apar Kishor P Ganti, Ramaswamy Govindan, Frederic W Grannis, Thierry Jahan, Mohammad Jahanzeb, David H Johnson, Anne Kessinger, Ritsuko Komaki, Feng-Ming Kong, Mark G Kris, Lee M Krug, Quynh-Thu Le, Inga T Lennes, Renato Martins, Janis O'Malley, Raymond U Osarogiagbon, Gregory A Otterson, Jyoti D Patel, Katherine M Pisters, Karen Reckamp, Gregory J Riely, Eric Rohren, George R Simon, Scott J Swanson, Douglas E Wood, Stephen C Yang.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20679538     DOI: 10.6004/jnccn.2010.0056

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  244 in total

1.  Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.

Authors:  Geoffrey R Oxnard; Yelena Y Janjigian; Maria E Arcila; Camelia S Sima; Samantha L Kass; Gregory J Riely; William Pao; Mark G Kris; Marc Ladanyi; Christopher G Azzoli; Vincent A Miller
Journal:  Clin Cancer Res       Date:  2011-08-10       Impact factor: 12.531

2.  The efficacy of first-line chemotherapy is associated with KRAS mutation status in patients with advanced non-small cell lung cancer: a meta-analysis.

Authors:  Yaxiong Zhang; Wenfeng Fang; Yue Yan; Mengyao Wang; Shiyang Kang; Jin Sheng; Jianhua Zhan; Nan Chen; Shaodong Hong; Yunpeng Yang; Yuxiang Ma; Dacheng He; Tao Qin; Ting Zhou; Yanna Tang; Xiaobo He; Wenhua Liang; Li Zhang
Journal:  Med Oncol       Date:  2015-02-08       Impact factor: 3.064

3.  Efficacy of mediastinal lymph node dissection during thoracoscopic lobectomy.

Authors:  Hanghang Wang; Thomas A D'Amico
Journal:  Ann Cardiothorac Surg       Date:  2012-05

4.  Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller.

Authors:  Jun-ichi Nitadori; Adam J Bograd; Kyuichi Kadota; Camelia S Sima; Nabil P Rizk; Eduardo A Morales; Valerie W Rusch; William D Travis; Prasad S Adusumilli
Journal:  J Natl Cancer Inst       Date:  2013-08-07       Impact factor: 13.506

Review 5.  New treatment options for lung adenocarcinoma--in view of molecular background.

Authors:  Nora Bittner; Gyula Ostoros; Lajos Géczi
Journal:  Pathol Oncol Res       Date:  2013-12-05       Impact factor: 3.201

6.  Complete video-assisted thoracic surgery right upper lobe sleeve resection.

Authors:  Renquan Zhang; Wanli Xia; Zaicheng Yu; Jianhui Zuo; Wei Liu; Yunhai Wang; Kechao Zhu
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

7.  Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.

Authors:  Zuen Ren; Shijie Zhou; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.

Authors:  Amjad Ali; Muhammad Zeeshan Bhatti; Abdus Saboor Shah; Hong-Quan Duong; Huda Mohammad Alkreathy; Shah Faisal Mohammad; Rahmat Ali Khan; Ayaz Ahmad
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

9.  Clinical investigation of EGFR mutation detection by pyrosequencing in lung cancer patients.

Authors:  Hee Joung Kim; Seo Young Oh; Wan Seop Kim; Sun Jong Kim; Gwang Ha Yoo; Won Dong Kim; Kye Young Lee
Journal:  Oncol Lett       Date:  2012-10-01       Impact factor: 2.967

10.  Synergistic effect of fenretinide and curcumin for treatment of non-small cell lung cancer.

Authors:  Huanxian Chen; Linmin Chen; Liang Wang; Xinhua Zhou; Judy Yuet-Wa Chan; Jingjing Li; Guozhen Cui; Simon Ming-Yuen Lee
Journal:  Cancer Biol Ther       Date:  2016-09-15       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.